Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Eli Lilly launches new form of obesity drug Zepbound

Digest more
Top News
Overview
Impacts
 · 10h · on MSN
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

Continue reading

 · 6h · on MSN
Eli Lilly’s Zepbound gets FDA OK for multi-dose pen
Dailymotion on MSN · 7h
Eli Lilly launches multi-dose Zepbound pen to drive obesity drug growth
 · 7h
Eli Lilly’s Zepbound Gets FDA OK for Multi-Dose Pen
Eli Lilly LLY 5.34% received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery option for patients.

Continue reading

 · 2h
Novo Nordisk’s stock closes at 4-year low after its next-gen weight-loss drug lost to Lilly’s in Phase 3 trial
Axios · 6h
Novo Nordisk slumps further on weight loss drugs in fight with Eli Lilly
 · 10h
Lilly to launch multi-dose weight-loss drug device in US
Zepbound KwikPen will be available starting at $299 per month for the 2.5-milligram dose for cash-paying customers

Continue reading

 · 9h
Novo Nordisk’s New Weight Loss Shot Loses To Rival Eli Lilly In Clinical Trial—Stock Plummets
 · 14h
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
7hon MSN

FDA proposes new treatment approval pathway for ultrarare diseases

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed regulatory pathway for individualized therapies,
5d

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals.
Fitgurú on MSN
7h

Weight loss drug may offer new hope for alcohol addiction treatment

A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.
9d

It's a dangerous complication of pregnancy — but a new drug holds promise

Researchers celebrate early results of a drug that may become the first treatment for a serious complication of pregnancy called preeclampsia. It's got the potential to save many lives.
5d

New VA rule could lower veterans’ disability rating if medication improves their symptoms

The new rule might mean that veterans receive lower disability ratings from the VA, officials from major veterans service organizations said.
News On 6
2d

Advances in amyloidosis treatment improve survival rates

These drugs reduce production of the abnormal transthyretin protein in the liver, which is responsible for many cases of cardiac amyloidosis. Doctors report that the medications have led to fewer major cardiac events, reduced hospitalizations and improved quality of life for patients.
Pancreatic Cancer Action Network
6d

FDA Approves New Treatment for Patients with Locally Advanced Pancreatic Cancer: What You Need to Know

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.
4d

How a Heart Medication Could Unlock a New Non-Toxic Cancer Treatment Strategy

Researchers have uncovered a new way to attack lymphoma by targeting a non-catalytic region of a key regulatory enzyme, rather than its traditional active site. Researchers at VCU Massey Comprehensive
KOAT Albuquerque
2mon

New menopause drug gives women a non-hormonal choice

ACCORDINGLY. BACK TO YOU, MY FRIEND. THANKS, CORY. FOR MANY WOMEN, HOT FLASHES AND NIGHT SWEATS CAN MAKE MENOPAUSE A REAL CHALLENGE. THE FDA JUST APPROVED A NEW NON-HORMONAL DRUG TO HELP KOAT UNM HEALTH EXPERT DOCTOR ASH SPOKE ABOUT IT WITH OUR DARLENE ...
Daily Voice on MSN
11h

Most common medications used by US adults revealed in new study

Many Americans reach for medicine far more often than they may realize, according to a new national survey that highlights just how common weekly medication use has become. A study published in JAMA Network Open on Monday,
  • Privacy
  • Terms